← Back to markets
Halozyme Therapeutics
HALO · Health Care · Biotechnology
$101.76-1.34%
RS +42.6
Returns
| 7D | +24.9% |
| 1M | +31.2% |
| 3M | +58.2% |
| 6M | +31.5% |
| YTD | +53.2% |
| 1Y | +65.5% |
About Halozyme Therapeutics
Halozyme Therapeutics, Inc. is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment.